Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Brucellosis
4.2.2 Increasing Awareness about Animal Health
4.3 Market Restraints
4.3.1 Stringent Regulation for Animal Vaccines
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value ?“ USD million)
5.1 By Vaccine Type
5.1.1 DNA Vaccine
5.1.2 Subunit Vaccine
5.1.3 Vector Vaccine
5.1.4 Recombinant Vaccine
5.2 By Application
5.2.1 Cattle
5.2.2 Sheep & Goat
5.2.3 Others
5.3 By End User
5.3.1 Veterinary Hospitals & Clinics
5.3.2 Animal Care Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4 Middle East
5.4.5 South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ceva
6.1.2 Colorado Serum Company
6.1.3 CZ Vaccines
6.1.4 Fivet Animal Health
6.1.5 Hester Biosciences Limited
6.1.6 Indian Immunologicals Ltd.
6.1.7 Jordan Bio-industries Center
6.1.8 Laboratories Tornel
6.1.9 Merck & Co., Inc.
6.1.10 Veterinary Technologies Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS